These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2884466)
21. [Significance of alanine aminotransferase and reduction of post-transfusion non-A, non-B hepatitis]. Hoang B; Simonneau M; Le Xuan P; Guichoux P; Terrier E; Ruffie J Rev Fr Transfus Hemobiol; 1989 Apr; 32(2):93-106. PubMed ID: 2502996 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis C antibody and transaminase activities in blood donors. Morgan C; Hyland C; Young IF Lancet; 1990 Apr; 335(8694):921. PubMed ID: 1970011 [No Abstract] [Full Text] [Related]
23. [Incidence of anti-HCV and ALT in blood donors]. Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686 [TBL] [Abstract][Full Text] [Related]
26. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis]. Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897 [No Abstract] [Full Text] [Related]
27. [Prevention of post-transfusion hepatitis non-A, non-B. Report established by the National Agency for the Development of Medical Evaluation on demand of the General Health Direction]. Gayno S Gastroenterol Clin Biol; 1991; 15(8-9):667-8. PubMed ID: 1752387 [No Abstract] [Full Text] [Related]
28. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis. Bettigole R; Shastri KA J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794 [TBL] [Abstract][Full Text] [Related]
29. Screening for hepatitis C virus antibody. Lancet; 1989 Aug; 2(8661):505. PubMed ID: 2570213 [No Abstract] [Full Text] [Related]
35. The declining risk of post-transfusion hepatitis C virus infection. Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736 [TBL] [Abstract][Full Text] [Related]
36. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis]. Renger FG; Raabe A; Forster H; Knot E Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838 [No Abstract] [Full Text] [Related]
37. The usefulness of surrogate markers anti-HBc and ALT for post-transfusion non-A, non-B hepatitis prevention. Richard D J Virol Methods; 1987 Aug; 17(1-2):105-17. PubMed ID: 3117828 [TBL] [Abstract][Full Text] [Related]
38. Antibodies to hepatitis C and surrogate markers in blood donors. Koerner K; Stampe D; Glück D; Kubanek B Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427 [No Abstract] [Full Text] [Related]
39. Viral markers of hepatitis. Velasco M Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796 [No Abstract] [Full Text] [Related]
40. Screening of blood donations for hepatitis C virus antibody. Kimber RJ Med J Aust; 1990 Jun; 152(11):613. PubMed ID: 2112223 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]